MorphoSys AG
NASDAQ:MOR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
MorphoSys AG
NASDAQ:MOR
|
DE |
|
Mold-Tek Technologies Ltd
NSE:MOLDTECH
|
IN |
|
Photronics Inc
NASDAQ:PLAB
|
US |
|
T
|
Thales SA
XBER:CSF
|
FR |
|
Telix Pharmaceuticals Ltd
F:T3X
|
AU |
|
Genesis Minerals Ltd
ASX:GMD
|
AU |
|
Ajanta Soya Ltd
BSE:519216
|
IN |
|
K
|
Kerry Group PLC
F:KRZ
|
IE |
|
Corsa Coal Corp
XTSX:CSO
|
US |
|
Perusahaan Perkebunan London Sumatra Indonesia Tbk PT
OTC:PPLFF
|
ID |
|
P
|
PPB Group Bhd
KLSE:PPB
|
MY |
|
Paramount Communications Ltd
NSE:PARACABLES
|
IN |
|
Heartland Express Inc
NASDAQ:HTLD
|
US |
|
Straumann Holding AG
SIX:STMN
|
CH |
|
Quantumscape Corp
NYSE:QS
|
US |
|
Exro Technologies Inc
TSX:EXRO
|
CA |
|
Orange SA
XETRA:FTE
|
FR |
|
Kuros Biosciences AG
SIX:KURN
|
CH |
|
Silex Systems Ltd
ASX:SLX
|
AU |
|
Netex Knowledge Factory SA
MAD:NTX
|
ES |
|
W
|
Worthington Steel Inc
NYSE:WS
|
US |
|
Implenia AG
SIX:IMPN
|
CH |
|
Exact Sciences Corp
NASDAQ:EXAS
|
US |
|
T
|
TotalEnergies SE
F:TOTB
|
FR |
Bankruptcy Probability
MorphoSys AG's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
MorphoSys AG Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DE |
|
MorphoSys AG
XETRA:MOR
|
2.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
383.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
182.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
160.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
108.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
65.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
MorphoSys AG's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, MorphoSys AG has total debt of 255.2m EUR. This includes both short-term (0 EUR) and long-term (255.2m EUR) debt.
You can find a full breakdown on its Balance Sheet.
